SELLAS Life Sciences Group Inc (SLS)
0.9042
0.00 (0.00%)
USD |
NASDAQ |
Dec 23, 16:00
0.9042
0.00 (0.00%)
After-Hours: 20:00
SELLAS Life Sciences Group Enterprise Value: 42.36M for Dec. 20, 2024
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Microbot Medical Inc | 12.16M |
| Alaunos Therapeutics Inc | 1.566M |
| Galectin Therapeutics Inc | 144.36M |
| Oragenics Inc | 3.306M |
| Anavex Life Sciences Corp | 593.03M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.108M |
| Total Expenses (Quarterly) | 7.329M |
| EPS Diluted (Quarterly) | -0.10 |
| Earnings Yield | -76.31% |
| Normalized Earnings Yield | -237.13 |